XTI Aerospace, Inc. current report, 25 September 2015

Business Context and Reporting Period

This Form 8-K is filed by Sysorex Global Holdings Corp. (not XTI Aerospace, Inc.) on September 25, 2015. The report details the entry into a material definitive agreement for a public offering of common stock.

Key Financial Metrics

  • Shares Offered: 5,250,000 shares of common stock.
  • Offering Price: $1.00 per share.
  • Over-Allotment Option: Underwriters granted an option to purchase up to an additional 787,500 shares.
  • Expected Net Proceeds: Approximately $4.9 million (base); approximately $5.6 million if the over-allotment option is fully exercised.
  • Use of Proceeds: General corporate purposes, including business development, capital expenditures, working capital, and general and administrative expenses.
  • Closing Date: Scheduled for or about September 30, 2015.

Material Changes

The filing reports the execution of an underwriting agreement with B. Riley & Co., LLC. This represents a significant capital raise event. The filing does not provide comparative financial data (revenue, profit, or cash flow) for prior periods as this is a current report regarding a specific transaction rather than a periodic financial statement.

Outlook, Risks, and Management Commentary

  • Management Commentary: The company intends to utilize the net proceeds to fund business development and operational needs.
  • Risks and Contingencies: The closing of the offering is subject to customary closing conditions. The underwriting agreement includes standard representations, warranties, indemnification obligations, and termination provisions.
  • Regulatory Status: The offering is made pursuant to a previously effective Form S-3 registration statement (No. 333-204159).

Investor Verification Checklist

  • Verify the final closing date and whether the over-allotment option was exercised.
  • Confirm the actual net proceeds received after deducting all underwriting discounts and offering expenses.
  • Review the attached press releases (Exhibits 99.1 and 99.2) for additional strategic context.
  • Check subsequent filings to track the specific allocation of the raised capital.